Depression and quality of life in patients with coronary artery disease

J Robert Swenson1

  • 1University of Ottawa, Department of Psychiatry, The Ottawa Hospital, Box 400, 501 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada. jrswenson@ottawahospital.on.ca

Insights

Depression increases the risk of coronary artery disease (CAD) and adverse outcomes. Treatment for depression can improve prognosis and quality of life for patients with CAD.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Depression is a significant risk factor for developing coronary artery disease (CAD).
  • Depression negatively impacts morbidity and mortality rates in patients with existing CAD.
  • The link between mental health and cardiovascular health is a growing area of research.

Purpose of the Study:

  • To review recent studies on the relationship between depression and CAD.
  • To examine the effect of depression on the quality of life in CAD patients.
  • To discuss therapeutic interventions for depression in CAD patients and their outcomes.

Main Methods:

  • Literature review of recent studies.
  • Analysis of clinical trial data on psycho- and pharmacotherapy.
  • Evaluation of treatment impact on patient prognosis and quality of life.

Main Results:

  • Depression is a confirmed risk factor for CAD development and poorer outcomes.
  • Untreated depression significantly diminishes quality of life in CAD patients.
  • Psychotherapy and pharmacotherapy show promise in improving outcomes for this population.

Conclusions:

  • Addressing depression is crucial for managing CAD.
  • Effective treatment of depression can enhance both prognosis and quality of life for CAD patients.
  • Integrated care approaches are recommended for patients with comorbid depression and CAD.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...